Does LOMITAPIDE Cause Off label use? 206 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Off label use have been filed in association with LOMITAPIDE (Juxtapid). This represents 5.5% of all adverse event reports for LOMITAPIDE.
206
Reports of Off label use with LOMITAPIDE
5.5%
of all LOMITAPIDE reports
2
Deaths
23
Hospitalizations
How Dangerous Is Off label use From LOMITAPIDE?
Of the 206 reports, 2 (1.0%) resulted in death, 23 (11.2%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMITAPIDE. However, 206 reports have been filed with the FAERS database.
What Other Side Effects Does LOMITAPIDE Cause?
Diarrhoea (1,071)
Therapy cessation (828)
Weight decreased (828)
Nausea (567)
Abdominal pain upper (280)
Flatulence (244)
Abdominal discomfort (228)
Vomiting (211)
Fatigue (200)
Drug dose omission (185)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LOMITAPIDE Alternatives Have Lower Off label use Risk?
LOMITAPIDE vs LOMUSTINE
LOMITAPIDE vs LONAPEGSOMATROPIN-TCGD
LOMITAPIDE vs LONCASTUXIMAB TESIRINE-LPYL
LOMITAPIDE vs LOPERAMIDE
LOMITAPIDE vs LOPINAVIR